5.75% p.a. Early Redemption Worst of GOAL

Underlying: Lonza / Novartis / Roche SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 56631473 / ISIN: CH0566314735

Last update 14:45:03
  • Bid

    97.83 %
    Volume: 100'000

  • Ask

    98.83 %
    Volume: 100'000

CurrencyCHF
IssuerUBS AG, London Branch
Settlementphysical
Fixing date22.09.2020
Expiry22.09.2021
Sideways return7.00% / 8.16% p.a.
Unit price1'000.00 CHF
Underlying price1)
Lonza
Novartis
Roche

552.80 CHF
80.91 CHF
301.70 CHF
Display
  • Product chart
1) Prices are 15 Min. delayed